Cargando…
Development of glioblastoma organoids and their applications in personalized therapy
Glioblastomas (GBMs) are the brain tumors with the highest malignancy and poorest prognoses. GBM is characterized by high heterogeneity and resistance to drug treatment. Organoids are 3-dimensional cultures that are constructed in vitro and comprise cell types highly similar to those in organs or ti...
Autores principales: | Xu, Can, Yuan, Xiaoye, Hou, Pengyu, Li, Ziru, Wang, Changsheng, Fang, Chuan, Tan, Yanli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246443/ https://www.ncbi.nlm.nih.gov/pubmed/37283493 http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0061 |
Ejemplares similares
-
The Organoid Era Permits the Development of New Applications to Study Glioblastoma
por: Andreatta, Francesco, et al.
Publicado: (2020) -
Origin, activation, and targeted therapy of glioma-associated macrophages
por: Xu, Can, et al.
Publicado: (2022) -
Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
por: Kondo, Jumpei, et al.
Publicado: (2019) -
Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma
por: Ratliff, Miriam, et al.
Publicado: (2022) -
Organoid technology for personalized pancreatic cancer therapy
por: Bengtsson, Axel, et al.
Publicado: (2021)